The Short-Term Effects of Dry Cupping the Lumbar Paraspinal Muscles in Individuals With Non-speci… (NCT06469762) | Clinical Trial Compass
CompletedNot Applicable
The Short-Term Effects of Dry Cupping the Lumbar Paraspinal Muscles in Individuals With Non-specific Low Back Pain
Canada52 participantsStarted 2024-11-01
Plain-language summary
This pilot study will investigate the effects of dry cupping the lumbar paraspinal muscles on lumbar spine on range of motion (ROM), blood flow as indicated by skin temperature, subjective pain, pressure pain threshold, perceived treatment effect and overall function in individuals experiencing Non-specific low back pain (NSLBP). The intervention will occur across three treatment sessions, scheduled approximately 48 hours apart. Both an intervention and placebo group will be used an a pre-/post- comparison will be conducted.
Who can participate
Age range
18 Years – 55 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Males and females;
* Between the ages of 18 - 55 years;
* Experiencing NSLBP; and
* Otherwise healthy, and successful completion of the GAQ (Should the participant be currently receiving treatment for NSLBP for another musculoskeletal condition, a wash out period of 2 days (48 hours) will be ensured between their treatment and study participation).
Exclusion Criteria:
* Any individual with a specific low back or lower body condition (e.g., i.e., spondylolisthesis, spinal stenosis, osteoporosis, intervertebral disk derangement);
* Any individual with a previous or scheduled surgery to the lower body, which may affect their hip and/or knee ROM;
* Any individual with previous trauma to the lower back area;
* Any individual who is diagnosed with cancer;
* Any individual experiencing referred leg symptoms;
* Any individual who is confirmed or suspected to be pregnant; and
* Any individual with a confirmed or suspected blood/blood clotting disorder (i.e., hemophiliac).
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
The Numeric Pain Rating Scale (NPRS)
Timeframe: Pre-intervention #1, immediately after intervention #1, pre-intervention #2, immediately after intervention #2, pre-intervention #3, immediately after intervention #3
2
Algometry
Timeframe: Pre-intervention #1, immediately after intervention #1, pre-intervention #2, immediately after intervention #2, pre-intervention #3, immediately after intervention #3